 | This article has multiple issues. Please helpimprove it or discuss these issues on thetalk page.(Learn how and when to remove these messages) (Learn how and when to remove this message)
|
John H. Abeles is an American-basedventure investor, director, consultant, entrepreneur, andphilanthropist.[citation needed]
He was a director of the International Opera Alliance, New York[1] and was a member ofThe Players Club, a theatre-themed social club. He also was on the board ofthe New Group, a theater organization in New York.[2] He served on the advisory board of the College of Chemistry atUniversity of California, Berkeley.
Abeles is the president and founder of MedVest, Inc. He is the managing member of Dalyda Finance LLC. Abeles is the founder, sole investor and general partner of Northlea Partners LLLP. He is chairman of UniMedica Inc.[3]
Abeles is the founder and chairman of BryoLogyx, which licensed a synthetic form of bryostatin-1 from Stanford University for the use in cancer immunotherapy and adjunctive therapy.
Abeles received his medical degree as well as a degree in pharmacology from theUniversity of Birmingham.[4]
Abeles has three children (David, Lynne and Daniel), all successful NYC performing artists in drama and music as well as four granddaughters and two grandsons.
